North Carolina Health Equity Project, Inc.

Leveraging the power of emerging AI technologies to improve health outcomes for all people.™

Join our Mailing List
  • Home

  • About

    • Leadership
    • James Burroughs
  • Blog

  • Research

  • Advocacy

  • Contact

    • Subscribe
  • News

  • Governance

    • Corporate
    • Standards
    • Data Stewardship and ISMS
    • EEO Compliance
    • Privacy
  • COVID-19 Dashboard

  • More

    Use tab to navigate through the menu items.

    +1 336-283-5094

    • All Posts
    • News
    • Research News
    • COVID-19 News
    • NCHEALTHEQ News
    • President's Corner
    • Health Policy
    • Technical Audience
    Search
    COVID-19 News Team
    • Jul 22, 2021
    • 1 min

    Newly Published: Effectiveness of Covid-19 Vaccines in UK against the B.1.617.2 (Delta) Variant

    JL Bernal et al. (2021) report on vaccine efficacy against variants in the United Kingdom, in an original article published (July 21,...

    12 views0 comments
    Staff Writer
    • Jul 19, 2021
    • 3 min

    ChAdOx1 nCoV-19 Vaccine and B.1.351 Variant of Concern, NCHEALTHEQ Submission to FDA

    We previously reported that vaccines developed from adenovirus isolate Y25-derived vectors, such as ChAdOx1, were not optimal for global...

    66 views0 comments
     

    North Carolina Health Equity Project, Inc.

    mail@nchealthequity.org

    +1 336-283-5094

    PO Box 36164, Greensboro, NC 27416

    • LinkedIn

    NCHEALTHEQ™ is a trademark of North Carolina Health Equity Project, Incorporated ("NCHEP"). About | Governance | Privacy © 2021, NCHEP or its affiliates.